ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $49,000 | +4.3% | 25,748 | +3.6% | 0.00% | – |
Q3 2015 | $47,000 | -67.4% | 24,848 | -20.2% | 0.00% | -100.0% |
Q2 2015 | $144,000 | -87.7% | 31,140 | -88.3% | 0.00% | -91.7% |
Q1 2015 | $1,166,000 | +50.1% | 266,900 | +19.3% | 0.01% | +140.0% |
Q4 2014 | $777,000 | +20.7% | 223,804 | +45.7% | 0.01% | +66.7% |
Q3 2014 | $644,000 | -12.3% | 153,600 | +22.7% | 0.00% | 0.0% |
Q2 2014 | $734,000 | -76.9% | 125,164 | -75.1% | 0.00% | -82.4% |
Q1 2014 | $3,171,000 | +64.0% | 503,264 | +52.3% | 0.02% | +70.0% |
Q4 2013 | $1,933,000 | +279.8% | 330,503 | +242.6% | 0.01% | +233.3% |
Q3 2013 | $509,000 | -68.0% | 96,480 | -53.3% | 0.00% | -70.0% |
Q2 2013 | $1,592,000 | – | 206,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |